WithdrawnNot Applicable

Minimally-invasive Non-surgical Therapy of Intrabony Defects

Stopped: Sponsorship was transferred as lead CI moved in 2019 and the trial was abandoned

Australia, Italy, Spain0Started 2019-02-01

Plain-language summary

This investigation aims to assess the clinical and radiographic outcomes of intrabony defects treated with minimally-invasive non-surgical therapy.

Who can participate

Age range

18 Years – 70 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. Age 18-70
. Diagnosis of Periodontitis (Tonetti et al. 2018)
. Presence of ≥1 'intrabony defect' (PPD and CAL \>5 mm with radiographic intrabony defect depth ≥3mm and not in a site associated with furcation involvement)
. Signed informed consent \[Participants must be able and willing to read and sign a copy of the "Informed Consent Form" (ICF) form after reading the "Patient Information Leaflet" (PIS), and after the nature of the study has been fully explained\].

Exclusion criteria

. Smoking (current or in past 5 years, including electronic cigarettes, vaping or similar)
. Medical history including diabetes or hepatic or renal disease, or other serious medical conditions or transmittable diseases
. Presence of drug-induced gingival enlargement
. History of conditions requiring prophylactic antibiotic coverage prior to invasive dental procedures
. Anti-inflammatory or anticoagulant therapy during the month preceding the baseline exam
. Systemic antibiotic therapy during the 3 months preceding the baseline exam,

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Radiographic whole defect depth reduction

Timeframe: 12 months

Trial details

NCT IDNCT03741374

SponsorQueen Mary University of London

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-04-02

View on ClinicalTrials.gov More Chronic Periodontitis trials